Randomized Phase III Study Comparing Paclitaxel-Bleomycin, Etoposide, and Cisplatin (BEP) to Standard BEP in Intermediate-Prognosis Germ-Cell Cancer: Intergroup Study EORTC 30983DE WIT, Ronald; SKONECZNA, Iwona; MARREAUD, Sandrine et al.Journal of clinical oncology. 2012, Vol 30, Num 8, pp 792-799, issn 0732-183X, 8 p.Article

A phase II study of pemetrexed and carboplatin in patients with locally advanced or metastatic breast cancerGARIN, August; MANIKHAS, Alexey; BIAKHOV, Mikhail et al.Breast cancer research and treatment. 2008, Vol 110, Num 2, pp 309-315, issn 0167-6806, 7 p.Article

Randomized Double-Blind Phase 2 Trial of 3 Doses of TAS-108 in Patients With Advanced or Metastatic Postmenopausal Breast CancerBUZDAR, Aman; VOGEL, Charles; SCHWARTZBERG, Lee et al.Cancer. 2012, Vol 118, Num 13, pp 3244-3253, issn 0008-543X, 10 p.Article

A randomised Phase III trial of glufosfamide compared with best supportive care in metastatic pancreatic adenocarcinoma previously treated with gemcitabineCIULEANU, Tudor E; PAVLOVSKY, Alexander V; BODOKY, Gyorgy et al.European journal of cancer (1990). 2009, Vol 45, Num 9, pp 1589-1596, issn 0959-8049, 8 p.Article

Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869: A randomized controlled trialVAN BELLE, Simon; LICHINITSER, Michael R; DE SMET, Marina et al.Cancer. 2002, Vol 94, Num 11, pp 3032-3041, issn 0008-543XArticle